Aroa Biosurgery Limited (AROAF)
OTCMKTS
· Delayed Price · Currency is USD
0.3500
0.00 (0.00%)
Jul 1, 2025, 4:00 PM EDT
Aroa Biosurgery Cash Flow Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
Net Income | -3.81 | -10.63 | -0.4 | -8.39 | -19.21 | Upgrade
|
Depreciation & Amortization | 4.27 | 4.3 | 3.83 | 3.13 | 3.05 | Upgrade
|
Other Amortization | 0.67 | 0.1 | - | 0.05 | 1.61 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.01 | - | 0.01 | 0 | 0 | Upgrade
|
Stock-Based Compensation | 2.16 | 3.18 | 2.58 | 2.97 | 1.99 | Upgrade
|
Other Operating Activities | 1.75 | 2.39 | 0.11 | 1.35 | 8.13 | Upgrade
|
Change in Accounts Receivable | -2.89 | 0.9 | -2.24 | -8.35 | -0.49 | Upgrade
|
Change in Inventory | -0.17 | -3.27 | -2.75 | -0.32 | 0.63 | Upgrade
|
Change in Accounts Payable | -0.4 | 0.11 | 1.84 | 1.32 | -0.3 | Upgrade
|
Change in Income Taxes | -0 | -0.03 | -0.39 | 0.09 | 0.41 | Upgrade
|
Change in Other Net Operating Assets | -4.16 | -4.42 | -6.39 | -3.38 | -0.83 | Upgrade
|
Operating Cash Flow | -2.57 | -7.38 | -3.77 | -11.52 | -5.01 | Upgrade
|
Capital Expenditures | -2.31 | -3.52 | -6.03 | -4.46 | -1.27 | Upgrade
|
Sale (Purchase) of Intangibles | -1.39 | -3.46 | -1.58 | -0.42 | -0.24 | Upgrade
|
Investment in Securities | 4 | 17.13 | 14.87 | -30 | -20 | Upgrade
|
Investing Cash Flow | 0.3 | 10.15 | 7.26 | -34.87 | -21.5 | Upgrade
|
Long-Term Debt Repaid | -1.01 | -0.74 | -0.65 | -10.09 | -12.92 | Upgrade
|
Net Debt Issued (Repaid) | -1.01 | -0.74 | -0.65 | -10.09 | -12.92 | Upgrade
|
Issuance of Common Stock | 0.01 | 0.11 | 0.17 | 50.32 | 34.95 | Upgrade
|
Other Financing Activities | -0.48 | -0.41 | -0.03 | -2.6 | 15.07 | Upgrade
|
Financing Cash Flow | -1.47 | -1.03 | -0.5 | 37.63 | 37.1 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.21 | 0.24 | 0.4 | -0.46 | 0.94 | Upgrade
|
Net Cash Flow | -3.53 | 1.98 | 3.38 | -9.22 | 11.53 | Upgrade
|
Free Cash Flow | -4.88 | -10.9 | -9.8 | -15.98 | -6.27 | Upgrade
|
Free Cash Flow Margin | -5.76% | -15.78% | -15.47% | -40.27% | -28.07% | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.03 | -0.03 | -0.05 | -0.02 | Upgrade
|
Cash Interest Paid | 0.48 | 0.5 | 0.38 | 1.73 | 1.26 | Upgrade
|
Cash Income Tax Paid | 0.56 | 0.27 | 0.57 | 0.02 | -0.23 | Upgrade
|
Levered Free Cash Flow | -5.26 | -11.84 | -11.88 | -13.56 | -8.58 | Upgrade
|
Unlevered Free Cash Flow | -4.96 | -11.53 | -11.64 | -12.84 | -7.39 | Upgrade
|
Change in Net Working Capital | 6.54 | 5.45 | 8.5 | 9.34 | 6.32 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.